MEDIVATION, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 19 rows in 2008. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2008-12-03: Reporting owner Seely Lynn; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2008-10-31: Reporting owner Hung David; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2008-10-31: Reporting owner Seely Lynn; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2008-10-31: Reporting owner Machado Clarence Patrick; Form 4; Security Stock Option (right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2008-12-03 | Seely Lynn Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,000 288,000 owned after | $3.60 exercise price | 2008-12-05 | |
| 2008-10-31 | Hung David Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,000 150,000 owned after | $18.77 exercise price | 2008-11-03 | |
| 2008-10-31 | Seely Lynn Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $18.77 exercise price | 2008-11-03 | |
| 2008-10-31 | Machado Clarence Patrick Officer (Sr. Vice President and CFO) | 4 | Stock Option (right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $18.77 exercise price | 2008-11-03 | |
| 2008-10-31 | PALEKAR ROHAN Officer (Chief Commercial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $18.77 exercise price | 2008-11-03 | |
| 2008-10-31 | CHAKRAVARTY SARVAJIT Officer (VP of Medicinal Chemistry) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,195 14,195 owned after | $18.77 exercise price | 2008-11-03 | |
| 2008-10-31 | Protter Andrew A Officer (VP, Preclinical Development) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,510 14,510 owned after | $18.77 exercise price | 2008-11-03 | |
| 2008-09-25 | Seely Lynn Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,000 297,000 owned after | $3.60 exercise price | 2008-09-29 | |
| 2008-09-03 | Protter Andrew A Officer (VP, Preclinical Development) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −16,000 201,000 owned after | $5.35 exercise price | 2008-09-10 | |
| 2008-09-02 | Protter Andrew A Officer (VP, Preclinical Development) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,850 217,000 owned after | $5.35 exercise price | 2008-09-10 | |
| 2008-08-29 | Protter Andrew A Officer (VP, Preclinical Development) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,150 223,850 owned after | $5.35 exercise price | 2008-09-10 | |
| 2008-06-16 | Adams Daniel Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $13.93 exercise price | 2008-06-17 | |
| 2008-06-16 | Bailey Gregory Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $13.93 exercise price | 2008-06-17 | |
| 2008-06-16 | BLICKENSTAFF KIM D Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $13.93 exercise price | 2008-06-17 | |
| 2008-06-16 | VERNON W ANTHONY Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $13.93 exercise price | 2008-06-17 | |
| 2008-06-09 | Seely Lynn Officer (Chief Medical Officer) | 4 | Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,000 306,000 owned after | $3.60 exercise price | 2008-06-11 | |
| 2008-03-05 | Adams Daniel Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,190 81,520 owned after | $3.75 exercise price | 2008-03-10 | |
| 2008-03-03 | Seely Lynn Officer (Chief Medical Officer) | 4 | Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,000 315,000 owned after | $3.60 exercise price | 2008-03-05 | |
| 2008-01-15 | PALEKAR ROHAN Officer (Chief Commercial Officer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +300,000 300,000 owned after | $15.71 exercise price | 2008-01-16 |